drugset / Trial / NCT00804973
Study in Participants With Acute Migraines Headaches
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a Phase 2, multicenter, randomized, double-blind, placebo and active comparator-controlled study of LY2590443 in approximately 200 participants with migraines.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2590443 | Unknown | 200 mg | Oral |
| Comparator | Sumatriptan | Unknown | 6 mg | Other |